+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Urological Disorders Drugs Market Research Reports

Global Urinary Tract Infection Market (2023-2028) Competitive Analysis, Impact of Covid-19, Ansoff Analysis - Product Thumbnail Image

Global Urinary Tract Infection Market (2023-2028) Competitive Analysis, Impact of Covid-19, Ansoff Analysis

  • Report
  • February 2024
  • 155 Pages
  • Global
From
Hospital Acquired Disease Testing Market Report by Indication (UTI (Urinary Tract Infection), SSI (Surgical Site Infection), Pneumonia, Bloodstream Infections, MRSA (Methicillin-Resistant Staphylococcus Aureus), and Others), and Region 2024-2032 - Product Thumbnail Image

Hospital Acquired Disease Testing Market Report by Indication (UTI (Urinary Tract Infection), SSI (Surgical Site Infection), Pneumonia, Bloodstream Infections, MRSA (Methicillin-Resistant Staphylococcus Aureus), and Others), and Region 2024-2032

  • Report
  • January 2024
  • 143 Pages
  • Global
From
Sodium Bicarbonate - Global Strategic Business Report - Product Thumbnail Image

Sodium Bicarbonate - Global Strategic Business Report

  • Report
  • April 2024
  • 402 Pages
  • Global
From
Global Urinary Incontinence Market (2023-2028) by Product, Incontinence Type, Category, End User, Geography, Competitive Analysis, and Impact of Covid-19, Ansoff Analysis - Product Thumbnail Image

Global Urinary Incontinence Market (2023-2028) by Product, Incontinence Type, Category, End User, Geography, Competitive Analysis, and Impact of Covid-19, Ansoff Analysis

  • Report
  • February 2024
  • 171 Pages
  • Global
From
Global Genitourinary Drugs Market (2023-2028) Competitive Analysis, Impact of Covid-19, Ansoff Analysis - Product Thumbnail Image

Global Genitourinary Drugs Market (2023-2028) Competitive Analysis, Impact of Covid-19, Ansoff Analysis

  • Report
  • February 2024
  • 178 Pages
  • Global
From
Global Urinary Tract Infection Therapeutics Market - Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028 - Product Thumbnail Image

Global Urinary Tract Infection Therapeutics Market - Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028

  • Report
  • October 2023
  • 172 Pages
  • Global
From
Urinary Tract Infection Testing Market - Global Industry Size, Share, Trends, Opportunity, & Forecast 2018-2028 - Product Thumbnail Image

Urinary Tract Infection Testing Market - Global Industry Size, Share, Trends, Opportunity, & Forecast 2018-2028

  • Report
  • January 2024
  • 190 Pages
  • Global
From
Urinary Tract Infection Therapeutics - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029 - Product Thumbnail Image

Urinary Tract Infection Therapeutics - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029

  • Report
  • February 2024
  • 112 Pages
  • Global
From
Ascorbic Acid - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029 - Product Thumbnail Image

Ascorbic Acid - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029

  • Report
  • February 2024
  • 112 Pages
  • Global
From
Uncomplicated Urinary Tract Infections - Pipeline Insight, 2024 - Product Thumbnail Image

Uncomplicated Urinary Tract Infections - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 60 Pages
  • Global
From
Overactive Bladder Syndrome - Pipeline Insight, 2024 - Product Thumbnail Image

Overactive Bladder Syndrome - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 60 Pages
  • Global
From
Stress Urinary Incontinence - Pipeline Insight, 2024 - Product Thumbnail Image

Stress Urinary Incontinence - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 60 Pages
  • Global
From
Urinary Incontinence Including Neurogenic Bladder - Pipeline Insight, 2024 - Product Thumbnail Image

Urinary Incontinence Including Neurogenic Bladder - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 60 Pages
  • Global
From
Nocturnal Enuresis - Pipeline Insight, 2024 - Product Thumbnail Image

Nocturnal Enuresis - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Nocturia - Pipeline Insight, 2024 - Product Thumbnail Image

Nocturia - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 40 Pages
  • Global
From
Bladder Pain - Pipeline Insight, 2024 - Product Thumbnail Image

Bladder Pain - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Urinary Incontinence - Pipeline Insight, 2024 - Product Thumbnail Image

Urinary Incontinence - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Interstitial Cystitis - Pipeline Insight, 2024 - Product Thumbnail Image

Interstitial Cystitis - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Urinary Tract Infections - Pipeline Insight, 2024 - Product Thumbnail Image

Urinary Tract Infections - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 120 Pages
  • Global
From
Cystinuria - Pipeline Insight, 2024 - Product Thumbnail Image

Cystinuria - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Loading Indicator

The Urological Disorders Drugs market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs used to treat urological disorders. These disorders include urinary tract infections, bladder control issues, kidney stones, prostate cancer, and erectile dysfunction. Companies in this market develop and market drugs that can help to reduce the symptoms of these disorders, as well as provide treatments for them. Some of the major players in the Urological Disorders Drugs market include Pfizer, Merck, AstraZeneca, GlaxoSmithKline, and Sanofi. These companies have a wide range of products that are used to treat urological disorders, including antibiotics, antifungals, and anti-inflammatory drugs. Additionally, they have developed drugs that can help to reduce the symptoms of these disorders, such as pain relievers and muscle relaxants. Show Less Read more